Inmune Bio INMB
NASDAQ INMB
$1.93 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Inmune Bio (INMB) Cash from Investing Activities (2025)

Updated

Inmune Bio's Cash from Investing Activities was -$143,000 in Q4 2025.

Analysis

Inmune Bio (INMB) Cash from Investing Activities (2025) Analysis & Trends

For FY2025, Cash from Investing Activities at Inmune Bio came in at -$1.04 million.

  • In earlier years, Cash from Investing Activities was -$15 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Inmune Bio 53.37 Mn -38.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -143,000.00
Sep 30, 2025 -193,000.00
API Access

Inmune Bio Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=INMB&period=max&api_key=YOUR_API_KEY